Sign in

CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company

Edesa Biotech, Inc.

Sign in to watch
Ticker
EDSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(905) 475-1234
Business address
C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
Former names
Stellar Biotechnologies, Inc.
  1. 4 Open-market buy Chief Executive Officer bought 1,000 shares at $6.60 ($6,599)
  2. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $3.90 ($39,000)
  3. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $4.26 ($42,560)
  4. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $3.63 ($36,300)
  5. 4 Open-market buy Chief Executive Officer bought 3,000 shares at an average $2.09 ($6,280)
  6. 4 Open-market buy Chief Executive Officer bought 50,571 shares at an average $1.96 ($99,176)
  7. 4 Grant or award Chief Executive Officer acquired 82,236 shares (grant or award)
  8. 4 Grant or award Chief Executive Officer acquired 11,168 shares (grant or award)
  9. 4 Grant or award Chief Executive Officer acquired 10,444 shares (grant or award)
  10. 4 Grant or award Chief Executive Officer acquired 8,766 shares (grant or award)
  11. 4 Grant or award Chief Executive Officer acquired 6,968 shares (grant or award)
  12. 4 Grant or award Chief Executive Officer acquired 5,908 shares (grant or award)
  13. 4 Grant or award Chief Executive Officer acquired 5,981 shares (grant or award)
  14. 4 Grant or award Chief Executive Officer acquired 6,802 shares (grant or award)
  15. 4 Grant or award Chief Executive Officer acquired 7,186 shares (grant or award)
  16. 4 Grant or award Director acquired 11,000 shares (grant or award)
  17. 4 Grant or award Director acquired 11,000 shares (grant or award)
  18. 4 Grant or award Director acquired 20,001 shares (grant or award)
  19. 4 Grant or award Chief Executive Officer acquired 270,844 shares (grant or award)
  20. 4 Grant or award Director acquired 20,001 shares (grant or award)

Page 2 of 14 · 261 filings